1-20 of 26
Timothy J. McDonnell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, W. Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L. Jaye, Andrew L. Feldman
Journal: Blood
Blood (2024) 144 (19): 2063–2066.
https://doi.org/10.1182/blood.2024025681
Published: 2024
Includes: Supplemental data
Journal Articles

Tumor Genomics and Microenvironment Characterization of Diffuse Large B-Cell Lymphoma in Asian and Pacific Islander Patients

Michelle J. Lee, Kumudha Balakrishnan, Pavel Zemskiy, James D. Ayres, Timothy J. McDonnell, Neha Akkad, Kiril Kriukov, Arina Tkachuk, Ksenia Zornikova, Krystle Nomie, Aleksander Bagaev, Jean L. Koff, Christopher R. Flowers
Journal: Blood
Blood (2024) 144 (Supplement 1): 6209.
https://doi.org/10.1182/blood-2024-210739
Published: 2024
Journal Articles

Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients

Michelle J. Lee, Kumudha Balakrishnan, Arman Petrosyants, Daniil Wiebe, Chijioke Nze, Neha Akkad, Amy Ayers, James D. Ayres, Timothy J. McDonnell, Pavel Zemskiy, Kiril Kriukov, Alexander Nesmelov, Ksenia Zornikova, Krystle Nomie, Alexander Sarachakov, Nikita Kotlov, Ankur Singh, Jean L. Koff, Christopher R. Flowers
Journal: Blood
Blood (2024) 144 (Supplement 1): 4348.
https://doi.org/10.1182/blood-2024-210184
Published: 2024
Journal Articles

Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman-Fredricks, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L Jaye, Andrew L. Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3708.
https://doi.org/10.1182/blood-2023-179303
Published: 2023
Journal Articles

Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Raphael Mwangi, Grzegorz S. Nowakowski, Carla Casulo, Dai Chihara, Jonathon B. Cohen, Brad S. Kahl, Izidore S. Lossos, Peter Martin, Yucai Wang, Timothy J. McDonnell, Andrew L. Feldman, David L Jaye, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 3123.
https://doi.org/10.1182/blood-2023-174715
Published: 2023
Journal Articles

Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6 ) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications

Arushi Khurana, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers, Richard Burack, Izidore S. Lossos, Loretta J. Nastoupil, Andrew L. Feldman, Brad S. Kahl, Peter Martin, Grzegorz S. Nowakowski, Brian K. Link, Timothy J. McDonnell, Giorgio Inghirami, Sergei Syrbu, Kiran R. Vij, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Journal: Blood
Blood (2023) 142 (Supplement 1): 67.
https://doi.org/10.1182/blood-2023-190316
Published: 2023
Journal Articles

Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis

Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M Riska, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Grzegorz S. Nowakowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 2056–2058.
https://doi.org/10.1182/blood-2022-169433
Published: 2022
Journal Articles

Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab

Allison C. Rosenthal, Colleen Ramsower, Raphael Mwangi, Matthew J. Maurer, Diego Villa, Timothy J. McDonnell, Andrew L. Feldman, Thomas M. Habermann, Jonathon B. Cohen, Ryan S. Robetorye, Elías Campo, Eva Giné, James R. Cook, Brian T. Hill, Philipp Raess, German Ott, Alexander Reichart, David W. Scott, Lisa M. Rimsza
Journal: Blood
Blood (2021) 138 (Supplement 1): 3517.
https://doi.org/10.1182/blood-2021-151275
Published: 2021
Journal Articles

Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Final Phase II Results

Jason R. Westin, MD, Loretta J. Nastoupil, MD MSc, Luis Fayad, MD, Fredrick B. Hagemeister, MD, Yasuhiro Oki, MD, Francesco Turturro, MD, Sairah Ahmed, MD, Maria Alma Rodriguez, MD, Hun Ju Lee, Raphael Eric Steiner, MD, Ranjit Nair, MBBS,MD, Simrit Parmar, MBBS, Ken H. Young, Timothy J. McDonnell, MD PhD, Hubert Chuang, Michael R Green, PhD, Sattva S Neelapu, MD, Eric Davis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1581.
https://doi.org/10.1182/blood-2019-128475
Published: 2019
Journal Articles

Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database

Christopher Strouse, MD, Sarah C. Rutherford, MD, Brian J Smith, PhD, David L. Jaye, MD, Brad S. Kahl, MD, Izidore S. Lossos, MD, Carrie A. Thompson, MD, Jonathan W. Friedberg, MD, Andrew L. Feldman, MD, Carla Casulo, Jonathon B. Cohen, MDMS, Jennifer R Chapman, MD, Sergei Syrbu, MD PhD, Thomas E. Witzig, MD, Loretta J. Nastoupil, MD MSc, Timothy J. McDonnell, MD PhD, Melissa C Larson, MS, Thomas M. Habermann, MD, Susan L. Slager, PhD, Christopher R. Flowers, MD MS, James R. Cerhan, MD PhD, Peter Martin, FRCPC, MD MS, Brian K. Link, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1610.
https://doi.org/10.1182/blood-2019-126068
Published: 2019
Journal Articles

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States

Christopher R Flowers, MDMS, Brian K. Link, MD, Loretta J. Nastoupil, MD, Timothy J. McDonnell, MD PhD, Brad S Kahl, MD, Kiran R. Vij, MD, Carla Casulo, MD, Jonathan W. Friedberg, MD, Richard Burack, MD PhD, Izidore S. Lossos, MD, Carrie A. Thompson, MD, Kathleen J Yost, PhD, Francisco Vega, MD PhD, Sergei Syrbu, MD PhD, Peter Martin, FRCPC, MD MS, John P. Leonard, MD, Giorgio Inghirami, MD, Leon Bernal-Mizrachi, MD, Karen P. Mann, MD PhD, Cristine Allmer, BS, Julianne Lunde, MA, Matthew J. Maurer, MS, Susan L. Slager, PhD, Thomas M. Habermann, MD, David L. Jaye, MD, Andrew L. Feldman, MD, James R. Cerhan, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1702.
https://doi.org/10.1182/blood-2018-99-114281
Published: 2018
Journal Articles

Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Final Phase I/II Results

Jason R. Westin, MD, Yasuhiro Oki, MD, Loretta Nastoupil, MD, Luis Fayad, MD, Sattva S. Neelapu, MD, Francesco Turturro, MD, F. B. Hagemeister, MD, Maria Alma Rodriguez, MD, Hun Ju Lee, MD, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Richard J. Ford, MD PhD, R. Eric Davis, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 189.
https://doi.org/10.1182/blood.V130.Suppl_1.189.189
Published: 2017
Journal Articles

High Risk Diffuse Large B Cell Lymphoma: A Comparison of Aggressive Subtypes Treated with Dose Adjusted Chemotherapy-the University of Texas MD Anderson Experience

Vishwanath Sathyanarayanan, MD, Yasuhiro Oki, MD, Amir K Issa, MD, Mohamed Amin Ahmed, MD, Mansoor Noorani, Michelle A Fanale, MD, Fredrick B. Hagemeister, MD, Sattva S. Neelapu, MD, Loretta J. Nastoupil, MD, Nathan Fowler, MD, Francesco Turturro, MD, Eric Richard Davis, MD, Alma Rodriguez, MD, Michael Wang, MD, Lei Feng, MS, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Chelsea C Pinnix, MD PhD, Luis E. Fayad, MD, Jason R. Westin, MD
Journal: Blood
Blood (2016) 128 (22): 106.
https://doi.org/10.1182/blood.V128.22.106.106
Published: 2016
Journal Articles

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

Kristin A. Simar, RN, ANP-BC, Vishwanath Sathyanarayanan, MD, Amir K Issa, MD, Mohamed Amin Ahmed, MD, Mansoor Noorani, Michelle A Fanale, MD, Yasuhiro Oki, MD, F.B. Hagemeister, MD, Sattva S. Neelapu, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Francesco Turturro, MD, Richard Eric Davis, MD, Maria Alma Rodriguez, MD, Michael Wang, MD, Lei Feng, MS, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Chelsea C Pinnix, MD PhD, Luis E. Fayad, MD, Jason R. Westin, MD
Journal: Blood
Blood (2016) 128 (22): 4208.
https://doi.org/10.1182/blood.V128.22.4208.4208
Published: 2016
Journal Articles

Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I Results

Jason R. Westin, MD, Vishwanath Sathyanarayanan, MD, Luis E. Fayad, MD, Loretta J. Nastoupil, MD, Francesco Turturro, MD, Fredrick B. Hagemeister, MD, Kristin A. Simar, RN, ANP-BC, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Hubert H Chuang, MD PhD, Fazal Kamil, Lei Feng, MS, Eric Richard Davis, MD, Sattva S. Neelapu, MD, Yasuhiro Oki, MD
Journal: Blood
Blood (2016) 128 (22): 5395.
https://doi.org/10.1182/blood.V128.22.5395.5395
Published: 2016
Journal Articles

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

Jo Ishizawa, MD PhD, Kensuke Kojima, MD PhD, Dhruv Chachad, MS, Peter Ruvolo, PhD, Vivian Ruvolo, MS, Rodrigo Omar Jacamo, PhD, Gautam Borthakur, MD, Hong Mu, MD PhD, Zhihong Zeng, MD, Yoko Tabe, MD PhD, Joshua Allen, PhD, Zhiqiang Wang, PhD, Wencai Ma, PhD, Hans Lee, MD, Robert Z. Orlowski, PhD, MD, Dos D. Sarbassov, PhD, Sattva S. Neelapu, MD, Timothy J. McDonnell, MD PhD, Roberto N. Miranda, MD, Michael Wang, MD, Hagop M Kantarjian, MD, Marina Konopleva, MD PhD, Richard Eric Davis, MD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 2051.
https://doi.org/10.1182/blood.V126.23.2051.2051
Published: 2015
Journal Articles

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors

Wei Wang, Jorge E. Cortes, Pei Lin, Michael W. Beaty, Di Ai, Hesham M. Amin, Timothy J. McDonnell, Chi Young Ok, Hagop M. Kantarjian, L. Jeffrey Medeiros, Shimin Hu
Journal: Blood
Blood (2015) 126 (14): 1699–1706.
https://doi.org/10.1182/blood-2015-05-646489
Published: 2015
Includes: Supplemental data
Journal Articles

ONC201 Induces p53-Independent Apoptosis and Cell Cycle Arrest in Hematological Malignancies and Leukemic Stem/Progenitor Cells By Inducing ER Stress and mTOR Inhibition

Jo Ishizawa, MD PhD, Kensuke Kojima, MD PhD, Dhruv Chachad, MS, Peter P. Ruvolo, PhD, Vivian R Ruvolo, MA, Rodrigo Jacamo, PhD, Archana Dilip, MS, Hong Mu, MD PhD, Zhihong Zeng, MD, Polina Matre, PhD, Joshua E. Allen, PhD, Sattva S Neelapu, MD, Timothy J. McDonnell, MD PhD, Roberto N. Miranda, MD, Larry W. Kwak, MD PhD, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD, R Eric Davis, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3122.
https://doi.org/10.1182/blood.V124.21.3122.3122
Published: 2014
Journal Articles

ONC201 Exerts p53-Independent Cytotoxicity Through TRAIL and DR5 Induction In Mantle Cell Lymphomas

Jo Ishizawa, MD, PhD, Kensuke Kojima, MD, PhD, Archana Dilip, MS, Vivian R Ruvolo, MA, Bing Z Carter, PhD, Joshua E Allen, PhD, Sattva S. Neelapu, MD, Timothy J. McDonnell, MD, PhD, Mala Kiran Talekar, MD, Wafik S. El-Deiry, MD, Larry W. Kwak, MD, PhD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3822.
https://doi.org/10.1182/blood.V122.21.3822.3822
Published: 2013
Journal Articles

Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Bouthaina S. Dabaja, MD, Alexander Tzankov, MD, PhD, Carlo Visco, MD, Roberto N. Miranda, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, Wai Lap Choi, MD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres Ferreri, MD, PhD, Michael B. Moller, MD, PhD, Xiaoying Zhao, MD, Ronald S. Go, MD, Jane N. Winter, MD, Miguel Angel A. Piris, MD, PhD, Timothy J. McDonnell, MD, PhD, Yong Li, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 641.
https://doi.org/10.1182/blood.V122.21.641.641
Published: 2013